- Home
- Publications
- Publication Search
- Publication Details
Title
The safety of pharmacologic treatment for pediatric obesity
Authors
Keywords
-
Journal
Expert Opinion On Drug Safety
Volume 17, Issue 4, Pages 379-385
Publisher
Informa UK Limited
Online
2018-02-07
DOI
10.1080/14740338.2018.1437143
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Screening for Obesity and Intervention for Weight Management in Children and Adolescents
- (2017) Elizabeth A. O’Connor et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Screening for Obesity in Children and Adolescents
- (2017) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Is topiramate effective for migraine prevention in patients less than 18 years of age? A meta-analysis of randomized controlled trials
- (2017) Kai Le et al. JOURNAL OF HEADACHE AND PAIN
- Liraglutide in an Adolescent Population with Obesity: A Randomized, Double-Blind, Placebo-Controlled 5-Week Trial to Assess Safety, Tolerability, and Pharmacokinetics of Liraglutide in Adolescents Aged 12-17 Years
- (2017) Thomas Danne et al. JOURNAL OF PEDIATRICS
- Rethinking the Use of Body Mass Index z -Score in Children and Adolescents with Severe Obesity: Time to Kick It to the Curb?
- (2017) Aaron S. Kelly et al. JOURNAL OF PEDIATRICS
- The Limitations of Transforming Very High Body Mass Indexes into z -Scores among 8.7 Million 2- to 4-Year-Old Children
- (2017) David S. Freedman et al. JOURNAL OF PEDIATRICS
- BMI z -Scores are a poor indicator of adiposity among 2- to 19-year-olds with very high BMIs, NHANES 1999-2000 to 2013-2014
- (2017) David S. Freedman et al. Obesity
- Long-Term Outcome of Bariatric Surgery in Morbidly Obese Adolescents: a Systematic Review and Meta-Analysis of 950 Patients with a Minimum of 3 years Follow-Up
- (2017) Saeed Shoar et al. OBESITY SURGERY
- Tracking of BMIzScores for Severe Obesity
- (2017) David S. Freedman et al. PEDIATRICS
- Pediatric obesity pharmacotherapy: current state of the field, review of the literature and clinical trial considerations
- (2016) A S Kelly et al. INTERNATIONAL JOURNAL OF OBESITY
- Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events
- (2016) Rohan Khera et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Trends in Obesity Prevalence Among Children and Adolescents in the United States, 1988-1994 Through 2013-2014
- (2016) Cynthia L. Ogden et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Which Amount of BMI-SDS Reduction Is Necessary to Improve Cardiovascular Risk Factors in Overweight Children?
- (2016) Thomas Reinehr et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Comparable Liraglutide Pharmacokinetics in Pediatric and Adult Populations with Type 2 Diabetes: A Population Pharmacokinetic Analysis
- (2015) Kristin C. Carlsson Petri et al. CLINICAL PHARMACOKINETICS
- Cardiometabolic Risks and Severity of Obesity in Children and Young Adults
- (2015) Asheley C. Skinner et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
- (2015) Xavier Pi-Sunyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Predicting adult obesity from childhood obesity: a systematic review and meta-analysis
- (2015) M. Simmonds et al. Obesity Reviews
- Predicting Weight Loss and Maintenance in Overweight/Obese Pediatric Patients
- (2015) Susanna Wiegand et al. Hormone Research in Paediatrics
- Liraglutide's Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics in Pediatric Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial
- (2014) David J. Klein et al. Diabetes Technology & Therapeutics
- Topiramate use in pregnancy and the birth prevalence of oral clefts
- (2014) Daniel Mines et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Overweight and Obesity in Children and Adolescents
- (2014) Neslihan Koyuncuoğlu Güngör Journal of Clinical Research in Pediatric Endocrinology
- Effectiveness of Primary Care–Relevant Treatments for Obesity in Adults: A Systematic Evidence Review for the U.S. Preventive Services Task Force
- (2013) Erin S. LeBlanc et al. ANNALS OF INTERNAL MEDICINE
- Severe Obesity in Children and Adolescents: Identification, Associated Health Risks, and Treatment Approaches
- (2013) Aaron S. Kelly et al. CIRCULATION
- Addiction potential of phentermine prescribed during long-term treatment of obesity
- (2013) E J Hendricks et al. INTERNATIONAL JOURNAL OF OBESITY
- Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: The SCALE Maintenance randomized study
- (2013) T A Wadden et al. INTERNATIONAL JOURNAL OF OBESITY
- A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II)
- (2013) Caroline M. Apovian et al. Obesity
- Randomized Placebo-Controlled Clinical Trial of Lorcaserin for Weight Loss in Type 2 Diabetes Mellitus: The BLOOM-DM Study
- (2012) Patrick M. O'Neil et al. Obesity
- Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study
- (2011) W Timothy Garvey et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Evaluation of the Abuse Potential of Lorcaserin, a Serotonin 2C (5-HT2C) Receptor Agonist, in Recreational Polydrug Users
- (2011) M J Shram et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- A One-Year Randomized Trial of Lorcaserin for Weight Loss in Obese and Overweight Adults: The BLOSSOM Trial
- (2011) Meredith C. Fidler et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial
- (2011) Kishore M Gadde et al. LANCET
- Controlled-Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP)
- (2011) David B. Allison et al. Obesity
- Lorcaserin, A 5-HT2CReceptor Agonist, Reduces Body Weight by Decreasing Energy Intake without Influencing Energy Expenditure
- (2010) Corby K. Martin et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
- (2010) Frank L Greenway et al. LANCET
- Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management
- (2010) Steven R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects
- (2010) W. Philip T. James et al. NEW ENGLAND JOURNAL OF MEDICINE
- Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR-BMOD Trial
- (2010) Thomas A. Wadden et al. Obesity
- Benfluorex and valvular heart disease: a cohort study of a million people with diabetes mellitus
- (2010) Alain Weill et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Characterizing extreme values of body mass index–for-age by using the 2000 Centers for Disease Control and Prevention growth charts
- (2009) Katherine M Flegal et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- What reduction in BMI SDS is required in obese adolescents to improve body composition and cardiometabolic health?
- (2009) A. L Ford et al. ARCHIVES OF DISEASE IN CHILDHOOD
- Identification and treatment of metabolic complications in pediatric obesity
- (2009) Katie Larson Ode et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started